Variables | Disease free survival | Overall survival | ||||
---|---|---|---|---|---|---|
Hazard radio | 95% CI | p | Hazard radio | 95% CI | p | |
Gender | Â | Â | 0.382 | Â | Â | 0.4896 |
Male | 1 | Â | Â | 1 | Â | Â |
Female | 1.194 | 0.803–1.775 |  | 1.165 | 0.757–1.795 |  |
Age | Â | Â | 0.0294 | Â | Â | 0.0002 |
≤ 60 | 1 |  |  | 1 |  |  |
> 60 | 1.022 | 1.002–1.043 |  | 1.042 | 1.020–1.066 |  |
Stage | Â | Â | 0.0079 | Â | Â | 0.0002 |
I-II | 1 | Â | Â | 1 | Â | Â |
III | 1.59 | 1.129–2.239 |  | 2.026 | 1.404–2.923 |  |
Testin expression | Â | Â | <0.0001 | Â | Â | <0.0001 |
Low | 1 | Â | Â | 1 | Â | Â |
High | 0.193 | 0.130–0.287 |  | 0.141 | 0.090–0.219 |  |
Ki-67 | Â | Â | 0.2764 | Â | Â | 0.8062 |
≤ 30 | 1 |  |  | 1 |  |  |
> 30 | 1.209 | 0.859-1.700 |  | 1.047 | 0.725–1.513 |  |
pT status | Â | Â | 0.0548 | Â | Â | 0.0042 |
T1-T2 | 1 | Â | Â | 1 | Â | Â |
T3-T4 | 1.4 | 0.993–1.975 |  | 1.707 | 1.183–2.464 |  |
pN status | Â | Â | 0.0053 | Â | Â | 0.001 |
N0 | 1 | Â | Â | 1 | Â | Â |
N1-N3 | 1.62 | 1.154–2.272 |  | 1.844 | 1.280–2.658 |  |
Pathology | Â | Â | 0.3625 | Â | Â | 0.0559 |
S | 1 | Â | Â | 1 | Â | Â |
A-AS Mixed | 1.169 | 0.835–1.636 |  | 1.428 | 0.991–2.058 |  |
Differentiation | Â | Â | 0.0438 | Â | Â | 0.0953 |
Low-medium | 1 | Â | Â | 1 | Â | Â |
Medium-high | 0.707 | 0.505–0.990 |  | 0.734 | 0.511–1.056 |  |
Invasion | Â | Â | <0.0001 | Â | Â | 0.0055 |
None | 1 | Â | Â | 1 | Â | Â |
Yes | 2.022 | 1.421–2.877 |  | 1.714 | 1.171–2.507 |  |
Tumor size (cm) | Â | Â | 0.2377 | Â | Â | 0.2328 |
≤ 5 | 1 |  |  | 1 |  |  |
>5 | 1.267 | 0.855–1.876 |  | 1.288 | 0.850–1.950 |  |
Group | Â | Â | 0.0082 | Â | Â | 0.0264 |
NSCLC only | 1 | Â | Â | 1 | Â | Â |
PRISm or COPD | 1.29 | 1.068–1.558 |  | 1.262 | 1.028–1.551 |  |